MIR4681: A Drug Target / Disease Biomarker (G100616398)
MIR4681: A Drug Target / Disease Biomarker
MIR4681, also known as interleukin-4681, is a protein that is expressed in a variety of tissues throughout the body. It is a member of the interleukin-4 family, which includes several other proteins that play important roles in immune and inflammatory responses. MIR4681 has been shown to have several potential drug targets and may be a promising biomarker for certain diseases.
One of the key functions of MIR4681 is its role in the regulation of immune responses. MIR4681 has been shown to be involved in the development and maintenance of natural killer cells, which are a critical part of the immune system that helps to protect the body against infections and diseases. MIR4681 has also been shown to play a role in the regulation of T cell responses, which are another important part of the immune system.
In addition to its role in immune regulation, MIR4681 has also been shown to be involved in the regulation of cell signaling pathways. For example, MIR4681 has been shown to be involved in the regulation of the PI3K/Akt signaling pathway, which is a critical pathway that is involved in the regulation of many cellular processes, including cell growth, differentiation, and survival.
MIR4681 has also been shown to be involved in the regulation of inflammation. For example, MIR4681 has been shown to play a role in the regulation of the production of pro-inflammatory cytokines, which are important triggers of inflammation. MIR4681 has also been shown to be involved in the regulation of the recruitment of immune cells to sites of infection or inflammation, which is an important part of the immune response.
One of the potential drug targets for MIR4681 is its role in the regulation of immune responses. MIR4681 has been shown to play a critical role in the development and maintenance of natural killer cells, which are a critical part of the immune system that helps to protect the body against infections and diseases. Therefore, compounds that can modulate MIR4681 activity may be useful for the treatment of certain diseases.
Another potential drug target for MIR4681 is its role in the regulation of cell signaling pathways. MIR4681 has been shown to be involved in the regulation of the PI3K/Akt signaling pathway, which is a critical pathway that is involved in the regulation of many cellular processes, including cell growth, differentiation, and survival. Therefore, compounds that can modulate MIR4681 activity in this pathway may be useful for the treatment of certain diseases.
In addition to its potential drug targets, MIR4681 has also been shown to be involved in the regulation of inflammation. For example, MIR4681 has been shown to play a role in the regulation of the production of pro-inflammatory cytokines, which are important triggers of inflammation. Therefore, compounds that can modulate MIR4681 activity in this pathway may be useful for the treatment of certain inflammatory diseases.
Overall, MIR4681 is a protein that has been shown to play important roles in several cellular processes that are involved in immune and inflammatory responses. As such, compounds that can modulate MIR4681 activity may be useful for the treatment of a variety of diseases. Further research is needed to fully understand the role of MIR4681 in these processes and to identify potential drug targets.
Protein Name: MicroRNA 4681
The "MIR4681 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4681 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR4684 | MIR4685 | MIR4686 | MIR4687 | MIR4688 | MIR4689 | MIR4690 | MIR4691 | MIR4692 | MIR4693 | MIR4694 | MIR4695 | MIR4697 | MIR4697 host gene (non-protein coding) | MIR4698 | MIR4699 | MIR4700 | MIR4701 | MIR4703 | MIR4704 | MIR4706 | MIR4707 | MIR4708 | MIR4709 | MIR4711 | MIR4712 | MIR4713 | MIR4713HG | MIR4714 | MIR4715 | MIR4716 | MIR4717 | MIR4718 | MIR4720 | MIR4721 | MIR4722 | MIR4723 | MIR4724 | MIR4725 | MIR4726 | MIR4727 | MIR4728 | MIR4729 | MIR4730 | MIR4731 | MIR4732 | MIR4733 | MIR4734 | MIR4735 | MIR4736 | MIR4737 | MIR4738 | MIR4739 | MIR4740 | MIR4741 | MIR4742 | MIR4745 | MIR4746 | MIR4747 | MIR4749 | MIR4750 | MIR4751 | MIR4752 | MIR4753 | MIR4754 | MIR4755 | MIR4756 | MIR4757 | MIR4758 | MIR4759 | MIR4760 | MIR4761 | MIR4762 | MIR4763 | MIR4764 | MIR4765 | MIR4766 | MIR4767 | MIR4768 | MIR4769 | MIR4770 | MIR4771-1 | MIR4771-2 | MIR4772 | MIR4773-1 | MIR4773-2 | MIR4774 | MIR4775 | MIR4776-1 | MIR4776-2 | MIR4777 | MIR4778 | MIR4779 | MIR4780 | MIR4781 | MIR4782 | MIR4783 | MIR4784 | MIR4785 | MIR4786
